MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Data as of Sep 11, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch MDGL

See up to 3 months of MDGL. The 7-day demo opens the 1M and 3M ranges and puts MDGL on your watchlist.

Latest MDGL insider trades

William John Sibold - Officer
Open-market sale$69K
Sep 9, 2026
William John Sibold - Officer

About MADRIGAL PHARMACEUTICALS, INC. (MDGL)

MADRIGAL PHARMACEUTICALS, INC. files with the SEC under CIK 0001157601 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for MDGL on EDGAR

MDGL Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	35	14,747	$7.95M
Grant or award	2	1,725
Option exercise	2	100,000

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

MDGL insider transactions (Form 4)

127

59 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	131	$527.88^{footnote F2}	$69K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	347	$529.27^{footnote F3}	$184K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	522	$530.23^{footnote F4}	$277K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	368	$531.99^{footnote F5}	$196K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	512	$533.09^{footnote F6}	$273K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	396	$534.20^{footnote F7}	$212K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	644	$535.27^{footnote F8}	$345K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1,040	$536.11^{footnote F9}	$558K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	640	$537.17^{footnote F10}	$344K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	520	$538.30^{footnote F11}	$280K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	215	$539.03^{footnote F12}	$116K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	505	$540.19^{footnote F13}	$273K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	362	$541.65^{footnote F14}	$196K
Sep 9, 2026	William John Sibold - Officer	Open-market sale	Common Stock	160	$542.55^{footnote F15}	$87K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	60	$533.09^{footnote F17}	$32K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	106	$534.06^{footnote F18}	$57K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	218	$535.94^{footnote F19}	$117K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	160	$537.62^{footnote F20}	$86K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	687	$540.59^{footnote F21}	$371K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	368	$541.64^{footnote F22}	$199K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1,202	$542.60^{footnote F23}	$652K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1,539	$544.02^{footnote F24}	$837K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	761	$544.83^{footnote F25}	$415K
Sep 11, 2026	William John Sibold - Officer	Open-market sale	Common Stock	120	$546.38^{footnote F26}	$66K
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.49 to $528.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.54 to $529.51, inclusive. Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.64 to $530.48, inclusive. Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.57 to $532.28, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.57 to $533.29, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.58 to $534.57, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.63 to $535.62, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.64 to $536.45, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.56, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.70 to $538.65, inclusive. Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.86 to $539.83, inclusive. Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.86 to $540.47, inclusive. Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.29 to $542.27, inclusive. Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.42 to $542.68, inclusive. Footnote F17 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.76 to $533.64, inclusive. Footnote F18 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.76 to $534.48, inclusive. Footnote F19 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.52 to $536.02, inclusive. Footnote F20 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.235 to $538.00, inclusive. Footnote F21 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.97 to $540.90, inclusive. Footnote F22 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.00 to $541.73, inclusive. Footnote F23 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.11 to $543.02, inclusive. Footnote F24 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.27 to $544.20, inclusive. Footnote F25 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.38 to $545.32, inclusive. Footnote F26 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.28 to $546.56, inclusive.
Aug 17, 2026	Shannon T. Kelley - Officer	Open-market sale	Common Stock	664	$514.97	$342K
Aug 15, 2026	John C. Reed - Director	Grant or award	Common Stock	647	$0.00	-
Aug 15, 2026	John C. Reed - Director	Grant or award	Stock Option (Right to Buy)	1,078	$0.00	-
Jul 17, 2026	William John Sibold - Officer	Option exercise	Common Stock	50,000	-^{footnote F1}	-
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	140	$542.75^{footnote F3}	$76K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	110	$543.79^{footnote F4}	$60K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	545	$544.71^{footnote F5}	$297K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	275	$545.71^{footnote F6}	$150K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	269	$547.08^{footnote F7}	$147K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	680	$547.70^{footnote F8}	$372K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	47	$548.87^{footnote F9}	$26K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	153	$550.01^{footnote F10}	$84K
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1	$550.72	$551
Jul 20, 2026	William John Sibold - Officer	Open-market sale	Common Stock	280	$555.05^{footnote F11}	$155K
Jul 17, 2026	William John Sibold - Officer	Option exercise	Performance Restricted Stock Units	50,000	$0.00	-
Footnote F1 (price): On July 17, 2026, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 12. Pursuant to the terms of the award, certain of these shares were… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.22 to $543.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.26 to $544.25, inclusive. Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.31 to $545.28, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.31 to $546.29, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.37 to $547.35, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.40 to $548.29, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.42 to $549.39, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.70 to $550.24, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.10, inclusive.
Jun 17, 2026	Rebecca Taub - Director	Grant or award	Stock Option (Right to Buy)	766	$0.00	-
Jun 17, 2026	Rebecca Taub - Director	Grant or award	Common Stock	454	$0.00	-
Jun 17, 2026	Richard S. Levy - Director	Grant or award	Stock Option (Right to Buy)	766	$0.00	-
Jun 17, 2026	Richard S. Levy - Director	Grant or award	Common Stock	454	$0.00	-
Jun 17, 2026	Jacqualyn A. Fouse - Director	Grant or award	Stock Option (Right to Buy)	766	$0.00	-
Jun 17, 2026	Jacqualyn A. Fouse - Director	Grant or award	Common Stock	454	$0.00	-
Jun 17, 2026	James M. Daly - Director	Grant or award	Common Stock	454	$0.00	-
Jun 17, 2026	James M. Daly - Director	Grant or award	Stock Option (Right to Buy)	766	$0.00	-
Jun 17, 2026	Daniel J. Brennan - Director	Grant or award	Common Stock	404	$0.00	-
Jun 17, 2026	Daniel J. Brennan - Director	Grant or award	Stock Option (Right to Buy)	681	$0.00	-
Jun 17, 2026	BAKER BROS. ADVISORS LP	Grant or award	Common Stock	908^{footnote F1}	$0.00	-
Jun 17, 2026	BAKER BROS. ADVISORS LP	Grant or award	Non-Qualified Stock Options (right to buy)	1,532^{footnote F10}	$0.00	-
Jun 17, 2026	BAKER BROS. ADVISORS LP	Grant or award	Non-Qualified Stock Options (right to buy)	1,532^{footnote F10}	$0.00	-
Jun 17, 2026	BAKER BROS. ADVISORS LP	Grant or award	Common Stock	908^{footnote F1}	$0.00	-
Footnote F1 (shares): Includes 454 restricted stock units (each an "RSU") payable solely in common stock ("Common Stock") granted by Madrigal Pharmaceuticals, Inc. (the "Issuer") to each of Julian C. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP"), and Dr. Raymond Cheong… Full note on SEC EDGAR Footnote F10 (shares): Includes 766 Stock Options granted by the Issuer to each of Julian C. Baker and Dr. Cheong on June 17, 2026, pursuant to the 2026 Plan. The Stock Options have a strike price of $499.86, fully vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual… Full note on SEC EDGAR
Jun 1, 2026	David Soergel - Officer	Open-market sale	Common Stock	1,042	$495.74	$517K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	40	$506.68^{footnote F2}	$20K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	320	$508.24^{footnote F3}	$163K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	151	$510.36^{footnote F4}	$77K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	610	$511.40^{footnote F5}	$312K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	439	$512.50^{footnote F6}	$225K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	40	$512.97	$21K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	343	$514.67^{footnote F7}	$177K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	657	$515.92^{footnote F8}	$339K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	723	$516.87^{footnote F9}	$374K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	1,497	$517.59^{footnote F10}	$775K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	782	$518.76^{footnote F11}	$406K
May 22, 2026	Richard S. Levy - Director	Open-market sale	Common Stock	80	$519.98^{footnote F12}	$42K
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive. Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive. Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive. Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive.
May 18, 2026	David Soergel - Officer	Open-market sale	Common Stock	844	$515.90	$435K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	420	$426.86^{footnote F4}	$179K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	80	$427.85^{footnote F5}	$34K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	160	$429.00^{footnote F6}	$69K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	40	$429.58	$17K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	120	$430.90^{footnote F7}	$52K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	116	$432.56^{footnote F8}	$50K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	160	$434.20^{footnote F9}	$69K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	80	$435.32^{footnote F10}	$35K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	80	$436.69^{footnote F11}	$35K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	40	$437.65	$18K
Mar 4, 2026	Mardi Dier - Officer	Grant or award	Stock Option (Right to Buy)	6,519	$0.00	-
Mar 4, 2026	Mardi Dier - Officer	Grant or award	Common Stock	5,215	$0.00	-
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	646	$431.94	$279K
Mar 6, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	40	$425.08	$17K
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.46 to $427.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.50 to $428.19, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.51 to $429.24, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.66 to $431.04, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.41 to $432.99, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.82 to $434.58, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $435.26 to $435.37, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.46 to $436.92, inclusive.
Mar 4, 2026	William John Sibold - Officer	Grant or award	Common Stock	14,995	$0.00	-
Mar 6, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1,663	$431.94	$718K
Mar 4, 2026	William John Sibold - Officer	Grant or award	Stock Option (Right to Buy)	18,743	$0.00	-
Mar 4, 2026	Shannon T. Kelley - Officer	Grant or award	Common Stock	4,017	$0.00	-
Mar 6, 2026	Shannon T. Kelley - Officer	Open-market sale	Common Stock	360	$431.94	$155K
Mar 4, 2026	Shannon T. Kelley - Officer	Grant or award	Stock Option (Right to Buy)	5,022	$0.00	-
Mar 4, 2026	Carole Huntsman - Officer	Grant or award	Common Stock	3,989	$0.00	-
Mar 6, 2026	Carole Huntsman - Officer	Open-market sale	Common Stock	419	$431.94	$181K
Mar 4, 2026	Carole Huntsman - Officer	Grant or award	Stock Option (Right to Buy)	4,986	$0.00	-
Mar 6, 2026	Rebecca Taub - Director	Open-market sale	Common Stock	491	$431.94	$212K
Mar 4, 2026	David Soergel - Officer	Grant or award	Common Stock	4,374	$0.00	-
Mar 4, 2026	David Soergel - Officer	Grant or award	Stock Option (Right to Buy)	5,467	$0.00	-
Mar 2, 2026	Mardi Dier - Officer	Open-market sale	Common Stock	1,183	$427.21	$505K
Feb 23, 2026	Richard S. Levy - Director	Option exercise	Common Stock	2,500	$7.36	$18K
Feb 23, 2026	Richard S. Levy - Director	Option exercise	Stock Option (Right to Buy)	2,500	$0.00	-
Jan 26, 2026	Richard S. Levy - Director	Option exercise	Common Stock	4,000	$16.46	$66K
Jan 26, 2026	Richard S. Levy - Director	Option exercise	Stock Option (Right to Buy)	4,000	$0.00	-
Jan 26, 2026	Carole Huntsman - Officer	Open-market sale	Common Stock	340	$492.42	$167K
Jan 26, 2026	Carole Huntsman - Officer	Open-market sale	Common Stock	570	$494.59	$282K
Jan 26, 2026	William John Sibold - Officer	Open-market sale	Common Stock	1,577	$492.42	$777K
Jan 26, 2026	Rebecca Taub - Director	Open-market sale	Common Stock	647	$492.42	$319K
Jan 20, 2026	Shannon T. Kelley - Officer	Open-market sale	Common Stock	263	$490.77	$129K
Jan 20, 2026	Shannon T. Kelley - Officer	Open-market sale	Common Stock	429	$501.40	$215K
Jan 20, 2026	Rebecca Taub - Director	Open-market sale	Common Stock	2,238	$490.77	$1.10M
Jan 15, 2026	Rita Thakkar - Officer	Grant or award	Common Stock	2,398	$0.00	-
Jan 15, 2026	Rita Thakkar - Officer	Grant or award	Stock Option (Right to Buy)	1,826	$0.00	-
Dec 4, 2025	William John Sibold - Officer	Open-market sale	Common Stock	2,400	$575.34	$1.38M
Dec 3, 2025	William John Sibold - Officer	Option exercise	Common Stock	50,000	-^{footnote F1}	-
Dec 3, 2025	William John Sibold - Officer	Option exercise	Performance Restricted Stock Units	50,000	-^{footnote F3}	-
Footnote F1 (price): On December 3, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 3. Pursuant to the terms of the award, certain of these shares were… Full note on SEC EDGAR Footnote F3 (price): On September 11, 2023, the Reporting Person was granted a one-time sign-on award of Performance Restricted Stock Units with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a… Full note on SEC EDGAR
Dec 2, 2025	Mardi Dier - Officer	Option exercise	Common Stock	4,173	$251.63	$1.05M
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	320	$570.39^{footnote F2}	$183K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	410	$571.99^{footnote F3}	$235K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	354	$573.02^{footnote F4}	$203K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	717	$574.00^{footnote F5}	$412K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	120	$574.95^{footnote F6}	$69K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	240	$576.15^{footnote F7}	$138K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	320	$577.81^{footnote F8}	$185K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	258	$578.83^{footnote F9}	$149K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	480	$579.85^{footnote F10}	$278K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	240	$585.44^{footnote F11}	$141K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	240	$587.85^{footnote F12}	$141K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	160	$589.65^{footnote F13}	$94K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	160	$590.37^{footnote F14}	$94K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	74	$595.20^{footnote F15}	$44K
Dec 2, 2025	Mardi Dier - Officer	Open-market sale	Common Stock	80	$596.19^{footnote F16}	$48K
Dec 2, 2025	Mardi Dier - Officer	Option exercise	Stock Option (Right to Buy)	4,173	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.17 to $570.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.45 to $572.34, inclusive. Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.48 to $573.38, inclusive. Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.59 to $574.44, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.67 to $575.24, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.69 to $576.46, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.36 to $578.31, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.37 to $579.20, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.59 to $580.46, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.08 to $585.99, inclusive. Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $587.58 to $588.07, inclusive. Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.13 to $589.96, inclusive. Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.15 to $590.58, inclusive. Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.18 to $595.41, inclusive. Footnote F16 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.18 to $596.19, inclusive.

Recent MDGL Form 8-K filings

Read MDGL company news

Aug 12, 2026Item 5.02, 7.01, 9.01

Read the filing on SEC EDGAR

Jul 30, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 17, 2026Item 5.02, 5.07, 9.01

Read the filing on SEC EDGAR

May 6, 2026Item 2.02, 9.01

Recent MDGL Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 28, 2026	PAUL FRIEDMAN	Director	50,000	$25.83M	View on EDGAR
Sep 11, 2026	WILLIAM SIBOLD	Director, Officer	5,221

MDGL insider trading FAQ

What is the latest insider trade for MDGL?

MADRIGAL PHARMACEUTICALS, INC. (MDGL) had 4 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for MDGL runs to 59 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying MDGL stock?

No insider purchases of MDGL were filed in the last 90 days. 26 purchases are on record for this company.

How many insiders are selling MDGL stock?

35 insider sales of MDGL were filed in the last 90 days, totaling $7.95M.

Where can I see MDGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects MDGL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 11, 2026 - William John Sibold view on EDGAR
Aug 20, 2026 - Shannon T. Kelley view on EDGAR
Aug 18, 2026 - John C. Reed view on EDGAR
Jul 21, 2026 - William John Sibold view on EDGAR
Jun 18, 2026 - Rebecca Taub view on EDGAR
Jun 18, 2026 - Richard S. Levy view on EDGAR
Jun 18, 2026 - Jacqualyn A. Fouse view on EDGAR
Jun 18, 2026 - James M. Daly view on EDGAR
Jun 18, 2026 - Daniel J. Brennan view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where MDGL's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow MDGL with a 7-day demo

MDGL on your watchlist
Every MDGL Form 4 filing on record
Up to 3 months of MDGL price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

14,747

$7.95M

Grant or award

1,725

Option exercise

100,000

Date

Insider

Transaction

Security

Price

Value

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

131

$527.88^{footnote F2}

$69K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

347

$529.27^{footnote F3}

$184K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

522

$530.23^{footnote F4}

$277K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

368

$531.99^{footnote F5}

$196K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

512

$533.09^{footnote F6}

$273K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

396

$534.20^{footnote F7}

$212K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

644

$535.27^{footnote F8}

$345K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

1,040

$536.11^{footnote F9}

$558K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

640

$537.17^{footnote F10}

$344K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

520

$538.30^{footnote F11}

$280K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

215

$539.03^{footnote F12}

$116K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

505

$540.19^{footnote F13}

$273K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

362

$541.65^{footnote F14}

$196K

Sep 9, 2026

William John Sibold - Officer

Open-market sale

Common Stock

160

$542.55^{footnote F15}

$87K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

$533.09^{footnote F17}

$32K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

106

$534.06^{footnote F18}

$57K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

218

$535.94^{footnote F19}

$117K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

160

$537.62^{footnote F20}

$86K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

687

$540.59^{footnote F21}

$371K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

368

$541.64^{footnote F22}

$199K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

1,202

$542.60^{footnote F23}

$652K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

1,539

$544.02^{footnote F24}

$837K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

761

$544.83^{footnote F25}

$415K

Sep 11, 2026

William John Sibold - Officer

Open-market sale

Common Stock

120

$546.38^{footnote F26}

$66K

Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.49 to $528.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.54 to $529.51, inclusive.
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.64 to $530.48, inclusive.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.57 to $532.28, inclusive.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.57 to $533.29, inclusive.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.58 to $534.57, inclusive.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.63 to $535.62, inclusive.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.64 to $536.45, inclusive.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.56, inclusive.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.70 to $538.65, inclusive.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.86 to $539.83, inclusive.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.86 to $540.47, inclusive.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.29 to $542.27, inclusive.
Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.42 to $542.68, inclusive.
Footnote F17 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.76 to $533.64, inclusive.
Footnote F18 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.76 to $534.48, inclusive.
Footnote F19 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.52 to $536.02, inclusive.
Footnote F20 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.235 to $538.00, inclusive.
Footnote F21 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.97 to $540.90, inclusive.
Footnote F22 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.00 to $541.73, inclusive.
Footnote F23 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.11 to $543.02, inclusive.
Footnote F24 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.27 to $544.20, inclusive.
Footnote F25 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.38 to $545.32, inclusive.
Footnote F26 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.28 to $546.56, inclusive.

Aug 17, 2026

Shannon T. Kelley - Officer

Open-market sale

Common Stock

664

$514.97

$342K

Aug 15, 2026

John C. Reed - Director

Grant or award

Common Stock

647

$0.00

Aug 15, 2026

John C. Reed - Director

Grant or award

Stock Option (Right to Buy)

1,078

$0.00

Jul 17, 2026

William John Sibold - Officer

Option exercise

Common Stock

50,000

-^{footnote F1}

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

140

$542.75^{footnote F3}

$76K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

110

$543.79^{footnote F4}

$60K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

545

$544.71^{footnote F5}

$297K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

275

$545.71^{footnote F6}

$150K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

269

$547.08^{footnote F7}

$147K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

680

$547.70^{footnote F8}

$372K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

$548.87^{footnote F9}

$26K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

153

$550.01^{footnote F10}

$84K

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

$550.72

$551

Jul 20, 2026

William John Sibold - Officer

Open-market sale

Common Stock

280

$555.05^{footnote F11}

$155K

Jul 17, 2026

William John Sibold - Officer

Option exercise

Performance Restricted Stock Units

50,000

$0.00

Footnote F1 (price): On July 17, 2026, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 12. Pursuant to the terms of the award, certain of these shares were… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.22 to $543.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.26 to $544.25, inclusive.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.31 to $545.28, inclusive.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.31 to $546.29, inclusive.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.37 to $547.35, inclusive.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.40 to $548.29, inclusive.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.42 to $549.39, inclusive.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.70 to $550.24, inclusive.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.10, inclusive.

Jun 17, 2026

Rebecca Taub - Director

Grant or award

Stock Option (Right to Buy)

766

$0.00

Jun 17, 2026

Rebecca Taub - Director

Grant or award

Common Stock

454

$0.00

Jun 17, 2026

Richard S. Levy - Director

Grant or award

Stock Option (Right to Buy)

766

$0.00

Jun 17, 2026

Richard S. Levy - Director

Grant or award

Common Stock

454

$0.00

Jun 17, 2026

Jacqualyn A. Fouse - Director

Grant or award

Stock Option (Right to Buy)

766

$0.00

Jun 17, 2026

Jacqualyn A. Fouse - Director

Grant or award

Common Stock

454

$0.00

Jun 17, 2026

James M. Daly - Director

Grant or award

Common Stock

454

$0.00

Jun 17, 2026

James M. Daly - Director

Grant or award

Stock Option (Right to Buy)

766

$0.00

Jun 17, 2026

Daniel J. Brennan - Director

Grant or award

Common Stock

404

$0.00

Jun 17, 2026

Daniel J. Brennan - Director

Grant or award

Stock Option (Right to Buy)

681

$0.00

Jun 17, 2026

BAKER BROS. ADVISORS LP

Grant or award

Common Stock

908^{footnote F1}

$0.00

Jun 17, 2026

BAKER BROS. ADVISORS LP

Grant or award

Non-Qualified Stock Options (right to buy)

1,532^{footnote F10}

$0.00

Jun 17, 2026

BAKER BROS. ADVISORS LP

Grant or award

Non-Qualified Stock Options (right to buy)

1,532^{footnote F10}

$0.00

Jun 17, 2026

BAKER BROS. ADVISORS LP

Grant or award

Common Stock

908^{footnote F1}

$0.00

Footnote F1 (shares): Includes 454 restricted stock units (each an "RSU") payable solely in common stock ("Common Stock") granted by Madrigal Pharmaceuticals, Inc. (the "Issuer") to each of Julian C. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP"), and Dr. Raymond Cheong… Full note on SEC EDGAR
Footnote F10 (shares): Includes 766 Stock Options granted by the Issuer to each of Julian C. Baker and Dr. Cheong on June 17, 2026, pursuant to the 2026 Plan. The Stock Options have a strike price of $499.86, fully vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual… Full note on SEC EDGAR

Jun 1, 2026

David Soergel - Officer

Open-market sale

Common Stock

1,042

$495.74

$517K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

$506.68^{footnote F2}

$20K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

320

$508.24^{footnote F3}

$163K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

151

$510.36^{footnote F4}

$77K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

610

$511.40^{footnote F5}

$312K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

439

$512.50^{footnote F6}

$225K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

$512.97

$21K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

343

$514.67^{footnote F7}

$177K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

657

$515.92^{footnote F8}

$339K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

723

$516.87^{footnote F9}

$374K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

1,497

$517.59^{footnote F10}

$775K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

782

$518.76^{footnote F11}

$406K

May 22, 2026

Richard S. Levy - Director

Open-market sale

Common Stock

$519.98^{footnote F12}

$42K

Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive.
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive.

May 18, 2026

David Soergel - Officer

Open-market sale

Common Stock

844

$515.90

$435K

Mar 6, 2026